1. Immunization with Epstein-Barr Virus (EBV) peptide-pulsed dendritic cells induces functional CD8+ T-cell immunity and may lead to tumor regression in patients with EBV-positive nasopharyngeal carcinoma;Lin;Cancer Res,2002
2. Multiple risk factors of nasopharyngeal carcinoma: Epstein-Barr virus, malarial infection, cigarette smoking and familial tendency;Chen;Anticancer Res,1990
3. The role of Epstein-Barr virus in cancer;Pattle;Expert Opin Biol Ther,2006
4. Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma;Zheng;Cell Mol Immunol,2007
5. Molecular diagnosis of Epstein-Barr virus-related diseases;Gulley;J Mol Diagn,2001